Skip to main content

246 publications

Name Date Type Actions

Buyback programs - September 2023 (french)

Monthly communication regarding buyback programs

04/10/2023 Description of buyback programs

Rapport financier semestriel 2023 (french)

Rapport financier semestriel 2023 (french)

12/09/2023 Half Year Report

Buyback programs - August 2023 (french)

Monthly communication regarding buyback programs

12/09/2023 Description of buyback programs

2023 HALF-YEAR RESULTS

Sales: €256m (-5.4% as reported)
Essentials products sales: €151m (59% of Group sales)
Net income - Group share: €32m (12.6% of sales)
EBITDA*: €54m (20.9% of sales)
Cash-flow generation: €31m

07/09/2023 Public releases

2023 Half-Year Results

Contents
1.H1 2023 Highlights
2.H1 2023 Consolidatedfinancialstatements
3.Strategyand outlook

07/09/2023 Half Year Report

Buyback programs - July

Monthly communication regarding buyback programs 
 

22/08/2023 Description of buyback programs

Rapport financier semestriel 2022 (french)

Rapport financier semestriel 2022 (french)

26/06/2023 Half Year Report

Q1 2023 Sales: €145M

Vetoquinol recorded sales of €145 million for the first three months of the 2023 financial year, up 7.7% on a reported basis and 7.2% at constant exchange rates.

20/04/2023 Public releases

Availability of the 2022 universal registration document

On 13 April 2023, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format).

13/04/2023 Public releases

2022 ANNUAL RESULTS

Annual sales: €540m (up 3.6% as reported)
Essentials sales: €304m (up 4.5% as reported)
EBIT before depreciation of acquired assets: €99m (18.3% of sales)
Net income - Group share: €48m (8.9% of sales)
EBITDA: €118m (21.9% of sales)
Free cash-flow: €63m

23/03/2023 Public releases